A
APPLIED DNA SCIENCES INC — Investor Relations & Filings
Filings indexed
1,014
across all filing types
Latest filing
2026-04-29
Regulatory Filings
Country
US
United States of America
Listing
US
APDN
Applied DNA Sciences Inc. is a biotechnology company focused on the development and manufacture of DNA-based technologies for genetic medicine. The company's core expertise lies in polymerase chain reaction (PCR) and large-scale, cell-free enzymatic DNA synthesis. Its primary offering is lineaDNA™, a proprietary, linear form of DNA that serves as an alternative to plasmid DNA. This technology is designed for use in advanced therapeutic modalities, including the production of mRNA for vaccines and therapies, as well as for gene and cell therapies. Additionally, the company provides molecular and genomic diagnostic testing services through a clinical laboratory subsidiary.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - BNB PLUS CORP. (0000744452) (Filer) | 2026-04-29 | English | |
| SCHEDULE 13D - BNB PLUS CORP. (0000744452) (Subject) | 2026-03-25 | English | |
| 8-K - BNB PLUS CORP. (0000744452) (Filer) | 2026-03-24 | English | |
| 4 Filing | 2026-02-13 | English | |
| SCHEDULE 13G Filing | 2026-02-13 | English | |
| 10-Q Filing | 2026-02-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 38812512 | 8-K - BNB PLUS CORP. (0000744452) (Filer) | 2026-04-29 | English | ||
| 33036132 | SCHEDULE 13D - BNB PLUS CORP. (0000744452) (Subject) | 2026-03-25 | English | ||
| 33035001 | 8-K - BNB PLUS CORP. (0000744452) (Filer) | 2026-03-24 | English | ||
| 23508859 | 4 Filing | 2026-02-13 | English | ||
| 23508852 | SCHEDULE 13G Filing | 2026-02-13 | English | ||
| 23508947 | 10-Q Filing | 2026-02-12 | English | ||
| 32880548 | 8-K - APPLIED DNA SCIENCES INC (0000744452) (Filer) | 2026-02-05 | English | ||
| 18382849 | S-8 Filing | 2026-01-30 | English | ||
| 18382846 | 8-K Filing | 2026-01-22 | English | ||
| 18382848 | SCHEDULE 13G/A Filing | 2026-01-07 | English | ||
|
2025
5 filings
| |||||
| 18382843 | 424B3 Filing | 2025-12-30 | English | ||
| 18382852 | 10-K Filing | 2025-12-22 | English | ||
| 18382842 | S-1/A Filing | 2025-12-22 | English | ||
| 18382853 | 4 Filing | 2025-12-16 | English | ||
| 18382844 | 4 Filing | 2025-12-16 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
|
Alpha Tau Medical Ltd.
Clinical-stage oncology firm developing alpha radiation the…
|
DRTS | US | Professional, scientific and te… |
APPLIED DNA SCIENCES INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35347/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35347 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35347 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35347 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35347}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for APPLIED DNA SCIENCES INC (id: 35347)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.